跳至主要内容
临床试验/JPRN-UMIN000002059
JPRN-UMIN000002059未知未知

Research on the efficacy of eicosapentaenoic acid (EPA) on coronary plaque formation in patients undergoing percutaneous coronary intervention. - ReSPECT-Study Reduction of Soft Plaque by EPA, Clinical Tokushima Study

Cardiovascular Medicine. The University of Tokushima Institute of Health Biosciences, Graduate School.0 个研究点目标入组 40 人开始时间: 2009年6月20日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with a past history of hypersensitivity to high-purity EPA preparations. 2. Patients suffering a stroke within the previous 6 months. 3. Patients with a left vetricular ejection fraction of 40% or less. 4. Patients on dialysis. 5. Patients with bleeding (hemophilia, capilary fragility, gastrointestinal bleeding, urinary tract bleeding, hemoptysis, vitreous hemorrhaging etc.). 6. Patients with peptic ulcers. 7. Patients considered unsuitable for other reasons.

研究者

发起方
Cardiovascular Medicine. The University of Tokushima Institute of Health Biosciences, Graduate School.

相似试验